Skip to main content

Peer Review reports

From: Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers

Original Submission
30 Jan 2022 Submitted Original manuscript
1 Mar 2022 Reviewed Reviewer Report
30 Apr 2022 Reviewed Reviewer Report
25 May 2022 Author responded Author comments - Jin-Liang Kong
Resubmission - Version 2
25 May 2022 Submitted Manuscript version 2
27 May 2022 Author responded Author comments - Jin-Liang Kong
Resubmission - Version 3
27 May 2022 Submitted Manuscript version 3
31 May 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
13 Jun 2022 Editorially accepted
24 Jun 2022 Article published 10.1186/s12890-022-02036-5

You can find further information about peer review here.

Back to article page